Michael Jeng

Publications

• Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis. Abraham A, Alsultan A, Jeng M, Rodriguez-Galindo C, Campbell PK. Pediatr Blood Cancer. 2013; 60 (6): E19-22
• An exploratory epidemiological study of Langerhans cell histiocytosis. Venkatramani R, Rosenberg S, Indramohan G, Jeng M, Jubran R. Pediatr Blood Cancer. 2012; 59 (7): 1324-6
• Estimation of liver T₂ in transfusion-related iron overload in patients with weighted least squares T₂ IDEAL. Vasanawala SS, Yu H, Shimakawa A, Jeng M, Brittain JH. Magn Reson Med. 2012; 67 (1): 183-90
• Immune Thrombocytopenia in Children Less Than 1 Year of Age: A Single-institution 10-year Experience. Lo C, Wong W, Glader B, Jeng M. J Pediatr Hematol Oncol. 2012
• Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia. Grace RF, Bennett CM, Ritchey AK, Jeng M, Thornburg CD, Lambert MP, Neier M, Recht M, Kumar M, Blanchette V, Klaassen RJ, Buchanan GR, Kurth MH, Nugent DJ, Thompson AA, Stine K, Kalish LA, Neufeld EJ. Pediatr Blood Cancer. 2012; 58 (2): 221-5
• Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Yeh I, Bruckner AL, Sanchez R, Jeng MR, Newell BD, Frieden IJ. Pediatr Dermatol. 2011 May-Jun; 28 (3): 267-75
• Disseminated intravascular coagulation due to IgM-mediated autoimmune hemolytic anemia. Bleakly NT, Fontaine MJ, Pate LL, Sutherland SM, Jeng M. Pediatr Blood Cancer. 2011; 57 (2): 329-31
• Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease. Gyang E, Yeom K, Hoppe C, Partap S, Jeng M. Am J Hematol. 2011; 86 (1): 104-6
• The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Zhang B, Lo C, Shen L, Sood R, Jones C, Cusmano-Ozog K, Park-Snyder S, Wong W, Jeng M, Cowan T, Engleman EG, Zehnder JL. Blood. 2011; 117 (17): 4569-79
• Adherence to study medication and visits: data from the BABY HUG trial. Thornburg CD, Rogers ZR, Jeng MR, Rana SR, Iyer RV, Faughnan L, Hassen L, Marshall J, McDonald RP, Wang WC, Huang X, Rees RC. Pediatr Blood Cancer. 2010; 54 (2): 260-4
• Effects of a 6-week, individualized, supervised exercise program for people with bleeding disorders and hemophilic arthritis. Mulvany R, Zucker-Levin AR, Jeng M, Joyce C, Tuller J, Rose JM, Dugdale M. Phys Ther. 2010; 90 (4): 509-26
• Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasms. Hidalgo-Curtis C, Apperley JF, Stark A, Stark A, Jeng M, Gotlib J, Chase A, Cross NC, Grand FH. Br J Haematol. 2010; 148 (2): 268-73
• Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia. Jeng MR, O'Brien M, Wong W, Zoland J, Lea J, Tang N, Glader B. Haemophilia. 2009; 15 (6): 1272-80
• Neonatal alloimmune thrombocytopenia and neutropenia associated with maternal human leukocyte antigen antibodies. Gramatges MM, Fani P, Nadeau K, Pereira S, Jeng MR. Pediatr Blood Cancer. 2009; 53 (1): 97-9
• Clofarabine in refractory Langerhans cell histiocytosis. Rodriguez-Galindo C, Jeng M, Khuu P, McCarville MB, Jeha S. Pediatr Blood Cancer. 2008; 51 (5): 703-6
• Gene expression and pathway analysis of immune thrombocytopenic purpura. Sood R, Wong W, Gotlib J, Jeng M, Zehnder JL. Br J Haematol. 2008; 140 (1): 99-103
• Idiopathic neutropenia of childhood is associated with Fas/FasL expression. Nadeau KC, Callejas A, Wong WB, Joh JW, Cohen HJ, Jeng MR. Clin Immunol. 2008; 129 (3): 438-47
• Neonatal heparin overdose-a multidisciplinary team approach to medication error prevention. Arimura J, Poole RL, Jeng M, Rhine W, Sharek P. J Pediatr Pharmacol Ther. 2008; 13 (2): 96-8
• Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis. O'Brien MM, Lee-Kim Y, George TI, McClain KL, Twist CJ, Jeng M. Pediatr Blood Cancer. 2008; 50 (2): 381-3
• Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Porter J, Galanello R, Saglio G, Neufeld EJ, Vichinsky E, Cappellini MD, Olivieri N, Piga A, Cunningham MJ, Soulières D, Gattermann N, Tchernia G, Maertens J, Giardina P, Kwiatkowski J, Quarta G, Jeng M, Forni GL, Stadler M, Cario H, Debusscher L, Della Porta M, Cazzola M, Greenberg P, Alimena G, Rabault B, Gathmann I, Ford JM, Alberti D, Rose C. Eur J Haematol. 2008; 80 (2): 168-76
• Cold agglutinin syndrome in pediatric liver transplant recipients. Wong W, Merker JD, Nguyen C, Berquist W, Jeng M, Viele M, Glader B, Fontaine MJ. Pediatr Transplant. 2007; 11 (8): 931-6
• Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator. Harmatz P, Grady RW, Dragsten P, Vichinsky E, Giardina P, Madden J, Jeng M, Miller B, Hanson G, Hedlund B. Br J Haematol. 2007; 138 (3): 374-81
• Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Cappellini MD, Bejaoui M, Agaoglu L, Porter J, Coates T, Jeng M, Lai ME, Mangiagli A, Strauss G, Girot R, Watman N, Ferster A, Loggetto S, Abish S, Cario H, Zoumbos N, Vichinsky E, Opitz H, Ressayre-Djaffer C, Abetz L, Rofail D, Baladi JF. Clin Ther. 2007; 29 (5): 909-17
• Darbepoetin alfa and ferric gluconate ameliorate the anemia associated with recessive dystrophic epidermolysis bullosa. Kuo DJ, Bruckner AL, Jeng MR. Pediatr Dermatol. 2006 Nov-Dec; 23 (6): 580-5
• Application of a geographic information system to explore associations between air pollution and micronucleus frequencies in African American children and adults. Huen K, Gunn L, Duramad P, Jeng M, Scalf R, Holland N. Environ Mol Mutagen. 2006; 47 (4): 236-46
• Gene expression profile of idiopathic thrombocytopenic purpura (ITP). Sood R, Wong W, Jeng M, Zehnder JL. Pediatr Blood Cancer. 2006; 47 (5 Suppl): 675-7
• Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, Kalinyak KA, Hudes M, Bhatia S, Vichinsky EP. Br J Haematol. 2006; 135 (4): 574-82
• Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. Hankins J, Jeng M, Harris S, Li CS, Liu T, Wang W. J Pediatr Hematol Oncol. 2005; 27 (3): 158-61
• Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature. George TI, Jeng M, Berquist W, Cherry AM, Link MP, Arber DA. Pediatr Blood Cancer. 2005; 44 (3): 270-6
• Frequency of Fanconi anemia in Brazil and efficacy of screening for the FANCA 3788-3790del mutation. Magdalena N, Pilonetto DV, Bitencourt MA, Pereira NF, Ribeiro RC, Jeng M, Pasquini R. Braz J Med Biol Res. 2005; 38 (5): 669-73
• Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia. Jeng MR, Naidu PE, Rieman MD, Rodriguez-Galindo C, Nottage KA, Thornton DT, Li CS, Wiang WC. Pediatr Blood Cancer. 2005; 45 (2): 170-5
• Cow's milk allergy in a patient with hyper-IgE syndrome. Hernandez-Trujillo VP, Nguyen WT, Belleau JT, Jeng M, Conley ME, Lew DB. Ann Allergy Asthma Immunol. 2004; 92 (4): 469-74
• Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood. Thurston GB, Henderson NM, Jeng M. Clin Hemorheol Microcirc. 2004; 30 (1): 61-75
• Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood. Thurston GB, Henderson NM, Jeng M. Clin Hemorheol Microcirc. 2004; 30 (2): 83-97
• Extranodal Rosai-Dorfman disease in children. Rodriguez-Galindo C, Helton KJ, Sánchez ND, Rieman M, Jeng M, Wang W. J Pediatr Hematol Oncol. 2004; 26 (1): 19-24
• Hematologic problems in immigrants from Southeast Asia. Jeng MR, Vichinsky E. Hematol Oncol Clin North Am. 2004; 18 (6): 1405-22, x
• Natural history of moderate aplastic anemia in children. Howard SC, Naidu PE, Hu XJ, Jeng MR, Rodriguez-Galindo C, Rieman MD, Wang WC. Pediatr Blood Cancer. 2004; 43 (5): 545-51
• Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease. Jeng MR, Adams-Graves P, Howard TA, Whorton MR, Li CS, Ware RE. Am J Hematol. 2003; 74 (4): 243-8
• Liver transplantation for acute Budd-Chiari syndrome in identical twin sisters with Factor V leiden mutation. Nezakatgoo N, Shokouh-Amiri MH, Gaber AO, Grewal HP, Vera SR, Chamsuddin AA, Eshun JK, Jeng M. Transplantation. 2003; 76 (1): 195-8
• Resolution of chronic hepatic sequestration in a patient with homozygous sickle cell disease receiving hydroxyurea. Jeng MR, Rieman MD, Naidu PE, Kaste SC, Jenkins JJ, Serjeant G, Wang WC. J Pediatr Hematol Oncol. 2003; 25 (3): 257-60
• Central venous catheter complications in sickle cell disease. Jeng MR, Feusner J, Skibola C, Vichinsky E. Am J Hematol. 2002; 69 (2): 103-8
• Pseudotumor cerebri in two adolescents with acquired aplastic anemia. Jeng MR, Rieman M, Bhakta M, Helton K, Wang WC. J Pediatr Hematol Oncol. 2002; 24 (9): 765-8
• Summary of symposium: the future of stem cell transplantation for sickle cell disease. Woodard P, Jeng M, Handgretinger R, Wang W, Cunningham J. J Pediatr Hematol Oncol. 2002; 24 (7): 512-4
• Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Rodriguez-Galindo C, Kelly P, Jeng M, Presbury GG, Rieman M, Wang W. Am J Hematol. 2002; 69 (3): 179-84
• Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia. Jeng MR, Feusner J. Pediatr Hematol Oncol. 2001; 18 (2): 137-42
• Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells. Smith MT, Zhang L, Jeng M, Wang Y, Guo W, Duramad P, Hubbard AE, Hofstadler G, Holland NT. Carcinogenesis. 2000; 21 (8): 1485-90